A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, Drummond DC, Kim J, Noble C, Fitzgerald JB, Chang SM, Butowski NA, Taylor JW, Park JW, Prados MD

Publication

Cancer chemotherapy and pharmacology

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1209759

Publication Year

2017

PubMed ID

28233053

Publication Title

Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, Drummond DC, Kim J, Noble C, Fitzgerald JB, Chang SM, Butowski NA, Taylor JW, Park JW, Prados MD. A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemother Pharmacol. 2017 03; 79(3):603-610.